Genpact Down 20.8%, Analysts Lift Earnings Estimates and Value Scores
Genpact shares tumbled 20.8% over the past four weeks to enter technical oversold territory, indicating potential exhaustion of selling pressure. Meanwhile, Wall Street analysts have collectively raised fiscal 2026 earnings estimates and Zacks Style Scores rank Genpact among top value picks.
1. Stock Decline and Technical Oversold
Genpact shares declined 20.8% in the last month, pushing key momentum indicators such as the Relative Strength Index below 30 and signalling oversold conditions. This suggests that the recent selling pressure may have peaked and sets the stage for a rebound if buying interest returns.
2. Analyst Earnings Estimate Upgrades
Consensus forecasts for fiscal 2026 earnings per share have increased by an average of 4% over the past month as multiple Wall Street firms revised their models upward. These upward revisions reflect improving client demand trends in digital transformation and business process outsourcing services.
3. Zacks Style Scores Highlight Value
Zacks Style Scores assign Genpact an ‘A’ on value metrics, driven by its low price-to-earnings and price-to-book ratios relative to industry peers. This strong value ranking indicates the stock may be attractively priced for investors seeking undervalued opportunities.